Expedited Cyber Security
Summary:
A publicly traded life sciences company that had experienced rapid growth since its’ birth as a start-up needed to rapidly transform from informal practices and a minimal cybersecurity program to a scalable program that could meet several external compliance requirements (starting with SOC2). The Reveal Risk team assembled a deep pharma/life sciences team with prior leaders from several major pharmaceutical companies to drive a rapid but significant controls and program up-lift and readiness exercise.
Outcomes:
- Led a significant cultural shift (eye opening results from analysis and penetration tests that helped garner buy-in for necessary transformation to attain company business goals
- Brought organization, focus, and calm to prior scrambled efforts that had costly business impact
- Developed a clear and achievable roadmap for the future program, and enabling the cybersecurity program to be scalable and sustainable vs. reactionary
